Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer

Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer

Brain metastasis (BM), a devastating complication of advanced malignancy, has a high incidence in non-small cell lung cancer (NSCLC). As novel systemic treatment drugs and improved, more sensitive imaging investigations are performed, more patients will be diagnosed with BM. However, the main treatm...

Full description

Bibliographic Details
Main Authors: Yuchang Wang, Rui Chen, Yue Wa, Shikuan Ding, Yijian Yang, Junbo Liao, Lei Tong, Gelei Xiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Immunology
Subjects:
cancer
BM
immunotherapy
NSCLC
PD-1 inhibitor
PD-L1 inhibitor
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.829451/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.829451/full

Similar Items